-
Grand Pharma Announces the Latest Clinical Progress of New Crown Innovative Drugs, Product Prices are Expected to Be Affordable and Improve People's Accessibility
Time of Update: 2023-02-02
According to Grand Pharma's announcement, based on the results of the current positive clinical trial research, GS221 is expected to become a broad-spectrum anti-new coronavirus drug with good economic benefits, excellent therapeutic effect, safety and compliance after successful marketing approval, which is expected to greatly improve drug accessibility and reduce the economic pressure on the public to purchase drugs.
-
National Health Insurance Administration: Guard the bottom line of preventing large-scale return to poverty due to illness
Time of Update: 2023-02-02
In order to do a good job in the normalization of monitoring and assistance for low-income rural populations, further improve the accuracy and timeliness of assistance, and effectively prevent and re
-
Paxlovid failed to be included in the medical insurance catalogue The other two new crown drugs were successfully negotiated
Time of Update: 2023-02-02
According to China's National Medical Security Administration, the negotiation of the 2022 national medical insurance drug catalogue officially ended on January 8, and the combination packaging of ne
-
The "2022 White Paper on Healthy Hair Consumption of Urban People" was released, and more than 50% of the post-00s have hair loss problems
Time of Update: 2023-02-02
In recent years, the health awareness of the Chinese people has been continuously improved, and people have paid more attention to regulating their own health conditions, among which hair health has
-
On January 11, 17 pharmaceutical stocks in the two cities had block trading, and 3 of them had a turnover of more than 300 million yuan
Time of Update: 2023-02-01
In terms of average transaction price, the average transaction price of three stocks of Kaileying, BeiGene and Tigermed Pharma was more than 100 yuan, and the average transaction price of WuXi AppTec, Zhaoyan New Drug, Yifeng Pharmacy and Yunnan Baiyao exceeded 50 yuan.
-
The pharmaceutical sector is expected to usher in a recovery, and pharmaceutical companies are "rising"
Time of Update: 2023-02-01
Medical insurance negotiations and the continuous innovation and development of pharmaceutical companies themselves will continue to promote the release of innovative drugs and enter the harvest period.
-
In 2023, the pharmaceutical industry will continue to set off a wave of cooperation!
Time of Update: 2023-02-01
It is understood that before that, Biocytogen provided Hansen Pharmaceutical with candidate fully human antibody molecules for its selected targets generated by the "Thousand Mouse AntibodiesTM" project, and Hansen Pharmaceutical exercised the right to choose after completing the evaluation of candidate antibody molecules to reach the license agreement.
-
The CRO sector has moved up, and there is a stock 20CM up limit!
Time of Update: 2023-02-01
【Pharmaceutical Network Pharmaceutical Stock Market】January 11 news, CRO sector changes to rise, individual stocks, Nuotai Biotech 20CM up limit, Sirnaomics rose more than 9%, in addition, Kailaiying, Kanglong Chemical, Medixi, Zhaoyan New Drug, etc.
-
The pharmaceutical and biological industry rose 0.65% on January 9, and 1 individual stock rose to the limit
Time of Update: 2023-02-01
From the perspective of capital flow on January 9, the net outflow of main funds in the pharmaceutical and biological industry on the 9th was 1.
From the perspective of capital flow on January 9, the net outflow of main funds in the pharmaceutical and biological industry on the 9th was 1.
-
The price of Chinese medicinal materials has skyrocketed, and the cost of raw materials of Sunflower Pharmaceutical has increased!
Time of Update: 2023-02-01
Fourth, children's lung heat cough and asthma oral liquid raw material market comment Ephedra, the origin of Inner Mongolia has recently taken normal goods, the production area is about to end processing, the New Year is approaching, merchants have also taken holidays for the New Year, and the logistics of the origin have been suspended.
-
The field of APIs has "turned over", and the performance of a large number of enterprises has increased significantly
Time of Update: 2023-02-01
【Pharmaceutical Network Market Analysis】 Recently, with the gradual liberalization of epidemic prevention and control, the pharmaceutical market has attracted much attention from the capital market, e
-
In order to solve the development dilemma, the split and merger of pharmaceutical companies will become a "regular operation"
Time of Update: 2023-02-01
Not long ago, on December 19, 2022, Luye Pharmaceutical announced that Boan Biotech, a holding subsidiary and innovative biopharmaceutical company, entered the IPO stage and will be listed on the Hong Kong Stock Exchange.
-
Montmorillonite related concept stocks exploded! Many stocks such as Kangzhi Pharmaceutical had a 20CM price limit
Time of Update: 2023-02-01
As of the close of trading on January 3, the montmorillonite scattered index rose by more than 10% on the day, of which 5 stocks were up and down, namely Kangzhi Pharmaceutical, Tongyuan Pharmaceutical, Yiming Pharmaceutical, Fangsheng Pharmaceutical, China Resources Shuanghe, and many head stocks even had a 20CM price limit.
-
Under the increasing pressure of new drug research and development, pharmaceutical companies have begun to adjust the layout of innovation pipelines
Time of Update: 2023-02-01
In the future, as new drug research and development becomes more and more difficult and costly, the industry believes that more and more pharmaceutical companies will adjust their overall strategies based on the company's situation.
-
Oral implant centralized procurement and opening bidding, volume in exchange for price to "knock down" the price of dental implants
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];The Provincial Alliance for Oral Implant Systems opened bids in Chengdu on the 11th, which is the first attempt to expand the centralized procurement of high-value consumables from the medical insurance field to the non-medical insurance field.
-
Ministry of Civil Affairs: Establish a direct hotline between urban and rural communities and the pharmacies of medical institutions
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];On January 11, the joint prevention and control mechanism of the State Council held a press conference to introduce the relevant situation of epidemic prevention and control in key institutions and key places.
-
Innovative drugs and traditional Chinese medicine concept stocks continue to strengthen, and many stocks rose to the limit on January 16!
Time of Update: 2023-02-01
On the news, Hengrui Pharmaceutical issued an announcement on the evening of January 15 that the company recently received the "Drug Registration Certificate" of cyclophosphamide capsules approved and issued by the State Food and Drug Administration.
-
The traditional Chinese medicine sector will continue to strengthen, and the long-term development in these areas is also promising
Time of Update: 2023-02-01
In recent years, while continuously encouraging the innovation of traditional Chinese medicines and accelerating the review and approval, domestic policies are also further focusing on the quality, cl
-
How to improve the capacity of rural new crown severe disease treatment? Official response
Time of Update: 2023-02-01
3% from the peak 。 Jiao Yahui said that the detection rate of new crown positive infections in fever clinics also continued to decline, with a peak detection rate of 33.
-
Is there a "ravine" in the integration of medical and nursing care? Zhejiang deputies and members came up with a "medical" policy
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];In order to cope with the aging trend of Chinese population, a variety of integrated medical and elderly care service models such as "adding medical services in elderly care institutions" and "providing elderly care services by medical institutions" have emerged in the society.
